News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Oregon Bio View from Academia: Jackie Wirz, Ph.D. Part 2

A few weeks ago, we introduced a new occasional focus section called the View From Academia. We will spotlight the many leading professionals who work in our research universities and in our R&D community.  Today, we’re finishing our talk with Jackie Wirz, Ph.D., Assistant Dean for Graduate Studies and Director of Career and Professional Development at OHSU, where her job is to help students thrive and find success as new professionals. Here’s Part 2 of our discussion.

Q: How does your […]

August 16, 2019 |

Portland medical device maker raises $2M

By   – Staff Reporter, Portland Business Journal
Aug 8, 2019, 4:45pm EDT 
PBJ Article Link

Portland-based Sonivate Medical Inc. has raised more than $2 million, according to a form filed this week with the U.S. Securities and Exchange Commission.

The company, which makes a finger-mounted ultrasound probe, indicated it has about $900,000 yet to raise.

The last time we reported on Sonivate, in 2017, the company had just […]

August 13, 2019 |

OP-ED: Bioscience is moving the economic needle in Oregon

© 2019 by Daily Journal of Commerce. All rights reserved.

OP-ED: Bioscience is moving the economic needle in Oregon

An economic impact report released earlier this year showed Oregon’s 800-plus bioscience establishments contributed $6.5 billion to the state’s economy in 2017.

A new kid on the block is carving out space in the Oregon economy’s pecking order. Bioscience is a diverse array of establishments spanning industry, education and health care entities. It can be sorted into agricultural feedstock and industrial bioscience, drugs […]

August 8, 2019 |

Thermo Fisher, Genome Canada Ink C$6M Collaboration on Cancer NGS Assays

Jul 31, 2019 – staff reporter: genomeweb story link

NEW YORK – Thermo Fisher Scientific announced yesterday a three-year, C$6 million (US$4.5 million) collaboration with Genome Canada and the Ontario Institute for Cancer Research (OICR) to develop targeted next-generation sequencing-based assays and analysis software.

Under the terms of the agreement, the partners will develop three assays, one for rapid diagnosis of pancreatic cancer, and two for targeted treatments — in prostate and breast cancer.

The assays will simultaneously assess DNA and […]

August 1, 2019 |

NemaMetrix raises $5 million USD funding and strengthens senior team

Eugene, Oregon, USA, 29 July 2019: 

NemaMetrix, an Oregon-based company that provides phenotyping and functional analysis using C. elegans nematodes, today announced it has closed a $5 million USD funding round to expand its Precisome platform: a tool for in vivo testing for early drug discovery, agribio, and precision medicine. The platform provides rapid phenotypic analysis and functional assessment of humanized model organisms. The funding, led by Oregon Venture Fund, will accelerate the Company’s capacity to help researchers shorten their project timelines for testing disease […]

How does your company compare? Oregon Bio members get compensation survey data free for participating.

How does your compensation measure up?

Oregon Bio is partnering with Marsh & McLennan Agency to conduct a Total Rewards Survey. All bioscience companies, public and private doing business in Oregon are invited to take part. Members of Oregon Bio who participate will receive the report of aggregated data free of charge. The report will be released in the fall just in time for 2020 budgeting. HR professionals should email Julie Black to receive the easy-fill template. All data is […]

July 29, 2019 |

Oregon’s Biopharma Market Heats Up

Published: Jun 05, 2019 By Mark Terry for BioSpace

The Oregon Bioscience Association recently released a new economic impact report, showing that the state’s biopharma and life science industry is continuing to grow at a significant clip. This is consistent with what is currently known about the American Northwest, which is also the BioSpace Bio Forest Hotbed. For example, a recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle as […]

June 17, 2019 |

$10.7 billion: More biotech firms, more life research, more jobs and higher industry wages in Oregon make an increasingly larger economic impact in Oregon

Released in 2019

Oregon’s bioscience and R&D industry continues its steady and significant growth.

With its dedication to improving the quality of life for people around the world, Oregon’s growing life science industry continues to shine. From new and better therapies for cancer and heart disease to improvements in wound care, drug delivery methods and use of artificial intelligence to advance precision medicine, Oregon companies are at the forefront of innovation. Considering Oregon’s renowned academic and research institutions along with recent significant […]

May 24, 2019 |

Oregon bioscience sector jobs and economic impact pack a punch

By  – Staff Reporter, Portland Business Journal
May 23, 2019, 3:32pm EDT

Oregon is known more for its prowess in pinot noir than biosciences.

But bio’s economic footprint is about twice that of the wine industry, at $10.7 billion in 2017, according to a new study by Pinnacle Economics done for the Oregon Bioscience Association. Private bioscience concerns and public research institutions and hospitals directly generated $6.5 billion in economic […]

The dog days of summer are here and IPO activity has slowed, but that hasn't stopped some biotech companies from securing a place in the line leading to Wall Street. Late Friday, SpringWorks Ther [...]

The FDA approved the first spinal tether medical device to correct the most common form of scoliosis in children and adolescents--a ropelike implant that pulls the vertebrae into shape as the child gr [...]

A group of investors sued Novo Nordisk in Denmark for allegedly misleading the public about its insulin franchise's downward spiral. The lawsuit claims $1.75 billion in losses as pricing pressure [...]

Two of Roche's oncology blockbusters, Herceptin and Avastin, are facing dire straits as first-ever biosim competitors have entered the U.S. market. Now, a major insurer is putting its money on th [...]

Valeant changed its name to Bausch Healthcare last year to distance itself from controversy, but one of the company's old strategies--using price hikes to boost revenue--hasn't gone anywhere [...]

Alector and Prevail Therapeutics have traded blows over the work of Asa Abeliovich, a founder of both biotechs. The dispute centers on whether Abeliovich used Alector's confidential information i [...]

Roche's targeted cancer drug Rozlytrek officially has its U.S. green light--and in not just one but two cancer types. Thursday, the FDA cleared the med to treat ROS1-positive non-small cell lung [...]

GlaxoSmithKline poaches Merck KGaA's Maya Martinez-Davis to helm stateside pharma; Victor Bulto named Novartis U.S. pharma head; Allergan's Brent Saunders set for huge parachute. [...]